Published in Curr Hypertens Rev on August 01, 2012
Mindfulness meditation lowers muscle sympathetic nerve activity and blood pressure in African-American males with chronic kidney disease. Am J Physiol Regul Integr Comp Physiol (2014) 0.82
A randomized controlled longitudinal naturalistic trial testing the effects of automatic self transcending meditation on heart rate variability in late life depression: study protocol. BMC Complement Altern Med (2014) 0.79
Meditation and coronary heart disease: a review of the current clinical evidence. Ochsner J (2014) 0.78
The Effect of Chinese Herbal Medicine Gualouxiebaibanxia Decoction for the Treatment of Angina Pectoris: A Systematic Review. Evid Based Complement Alternat Med (2016) 0.75
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA (2003) 97.28
Heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation (2011) 31.98
Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med (1990) 17.52
Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med (1999) 16.30
Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association. Circulation (2011) 14.00
Racism as a stressor for African Americans. A biopsychosocial model. Am Psychol (1999) 11.00
A default mode of brain function: a brief history of an evolving idea. Neuroimage (2007) 8.85
Cardiovascular risk factors in childhood and carotid artery intima-media thickness in adulthood: the Cardiovascular Risk in Young Finns Study. JAMA (2003) 6.60
Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. J Am Coll Cardiol (2004) 6.50
Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med (1991) 6.08
Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N Engl J Med (1986) 6.05
Childhood cardiovascular risk factors and carotid vascular changes in adulthood: the Bogalusa Heart Study. JAMA (2003) 4.88
Blood pressure, systolic and diastolic, and cardiovascular risks. US population data. Arch Intern Med (1993) 4.59
New vistas for alpha-frequency band oscillations. Trends Neurosci (2007) 4.21
Trends in blood pressure among children and adolescents. JAMA (2004) 4.03
Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics. Circulation (1995) 3.82
Implications of small reductions in diastolic blood pressure for primary prevention. Arch Intern Med (1995) 3.71
Carotid intimal-medial thickness is related to cardiovascular risk factors measured from childhood through middle age: The Muscatine Study. Circulation (2001) 3.64
Psychosocial interventions for patients with coronary artery disease: a meta-analysis. Arch Intern Med (1996) 3.47
Focused attention, open monitoring and automatic self-transcending: Categories to organize meditations from Vedic, Buddhist and Chinese traditions. Conscious Cogn (2010) 3.12
Essential hypertension predicted by tracking of elevated blood pressure from childhood to adulthood: the Bogalusa Heart Study. Am J Hypertens (1995) 3.07
A randomised controlled trial of stress reduction for hypertension in older African Americans. Hypertension (1995) 2.85
A wakeful hypometabolic physiologic state. Am J Physiol (1971) 2.82
Effects of a randomized controlled trial of transcendental meditation on components of the metabolic syndrome in subjects with coronary heart disease. Arch Intern Med (2006) 2.73
Cardiovascular reactivity and development of preclinical and clinical disease states. Psychosom Med (2003) 2.69
Value of echocardiographic measurement of left ventricular mass in predicting cardiovascular morbid events in hypertensive men. Ann Intern Med (1986) 2.36
Ultrasound B-mode imaging in observational studies of atherosclerotic progression. Circulation (1993) 2.31
Toward understanding the association of socioeconomic status and health: a new challenge for the biopsychosocial approach. Psychosom Med (1995) 2.28
Meditation practices for health: state of the research. Evid Rep Technol Assess (Full Rep) (2007) 2.27
A prospective study of dehydroepiandrosterone sulfate, mortality, and cardiovascular disease. N Engl J Med (1986) 2.18
Atherosclerosis of the aorta and coronary arteries and cardiovascular risk factors in persons aged 6 to 30 years and studied at necropsy (The Bogalusa Heart Study). Am J Cardiol (1992) 2.15
Recent trends in violence-related behaviors among high school students in the United States. JAMA (1999) 2.01
The sympathetic system and hypertension. Am J Hypertens (2000) 1.90
Effects of immediate versus delayed antihypertensive therapy on outcome in the Systolic Hypertension in Europe Trial. J Hypertens (2004) 1.87
What does phase information of oscillatory brain activity tell us about cognitive processes? Neurosci Biobehav Rev (2008) 1.85
Systematic review of the efficacy of meditation techniques as treatments for medical illness. J Altern Complement Med (2006) 1.84
Sitting-meditation interventions among youth: a review of treatment efficacy. Pediatrics (2009) 1.76
A quantitative review of prospective evidence linking psychological factors with hypertension development. Psychosom Med (2002) 1.75
Obesity, insulin resistance, and cardiovascular disease. Recent Prog Horm Res (2004) 1.70
Stress reduction programs in patients with elevated blood pressure: a systematic review and meta-analysis. Curr Hypertens Rep (2007) 1.65
Impact of Transcendental Meditation on cardiovascular function at rest and during acute stress in adolescents with high normal blood pressure. J Psychosom Res (2001) 1.64
Differential effects of relaxation techniques on trait anxiety: a meta-analysis. J Clin Psychol (1989) 1.63
Physical activity and cardiovascular disease risk factors in children and adolescents: an overview. Can J Cardiol (2004) 1.62
Effects of stress reduction on carotid atherosclerosis in hypertensive African Americans. Stroke (2000) 1.59
Cardiovascular reactivity to the cold pressor test as a predictor of hypertension. Hypertension (1989) 1.56
Transcendental meditation, mindfulness, and longevity: an experimental study with the elderly. J Pers Soc Psychol (1989) 1.52
Effects of the Transcendental Meditation program on adaptive mechanisms: changes in hormone levels and responses to stress after 4 months of practice. Psychoneuroendocrinology (1997) 1.49
Interventions to reduce cardiovascular risk factors in children and adolescents. Am Fam Physician (1999) 1.47
Long-term effects of stress reduction on mortality in persons > or = 55 years of age with systemic hypertension. Am J Cardiol (2005) 1.46
A randomized controlled trial of stress reduction in African Americans treated for hypertension for over one year. Am J Hypertens (2005) 1.45
Physical activity and cardiovascular risk factors in children. Br J Sports Med (2011) 1.45
Ethnicity, gender, family history of myocardial infarction, and hemodynamic responses to laboratory stressors in children. Health Psychol (1993) 1.44
The physiology of meditation: a review. A wakeful hypometabolic integrated response. Neurosci Biobehav Rev (1992) 1.44
Cardiovascular reactivity to stress predicts future blood pressure status. Hypertension (1993) 1.40
Blood pressure response to transcendental meditation: a meta-analysis. Am J Hypertens (2008) 1.39
The role of triglycerides in atherosclerosis. Curr Cardiol Rep (2011) 1.38
Effects of volume expansion and contraction in normotensive whites, blacks, and subjects of different ages. Circulation (1979) 1.36
"Structural factor" in primary and secondary hypertension. Hypertension (1990) 1.32
Posttraumatic stress disorder among military returnees from Afghanistan and Iraq. Am J Psychiatry (2006) 1.31
Adrenocortical activity during meditation. Horm Behav (1978) 1.30
Stress reduction and preventing hypertension: preliminary support for a psychoneuroendocrine mechanism. J Altern Complement Med (1995) 1.29
Trial of stress reduction for hypertension in older African Americans. II. Sex and risk subgroup analysis. Hypertension (1996) 1.27
Usefulness of the transcendental meditation program in the treatment of patients with coronary artery disease. Am J Cardiol (1996) 1.25
Impact of transcendental meditation on ambulatory blood pressure in African-American adolescents. Am J Hypertens (2004) 1.25
Emotional and familial determinants of elevated blood pressure in black and white adolescent females. J Psychosom Res (1987) 1.25
Stressful events and individual beliefs as correlates of economic disadvantage and aggression among urban children. J Consult Clin Psychol (1995) 1.25
Sympathetic overactivity in hypertension. A moving target. Am J Hypertens (1996) 1.21
Medical care utilization and the transcendental meditation program. Psychosom Med (1987) 1.20
Patterns of EEG coherence, power, and contingent negative variation characterize the integration of transcendental and waking states. Biol Psychol (2002) 1.19
Coronary disease mortality and risk factors in black and white men. Results from the combined Charleston, SC, and Evans County, Georgia, heart studies. Arch Intern Med (1995) 1.18
Autonomic and EEG patterns distinguish transcending from other experiences during Transcendental Meditation practice. Int J Psychophysiol (2001) 1.18
Impact of stress reduction on negative school behavior in adolescents. Health Qual Life Outcomes (2003) 1.17
Hypertension in blacks: psychosocial and biological perspectives. J Hypertens (1989) 1.16
Twenty-four hour urinary cortisol and catecholamine excretion in combat-related posttraumatic stress disorder. Biol Psychiatry (1990) 1.16
Acute effects of transcendental meditation on hemodynamic functioning in middle-aged adults. Psychosom Med (1999) 1.15
All approaches to preventing or reversing effects of stress are not the same. Am J Health Promot (1998) 1.14
A controlled study of the effects of the Transcendental Meditation program on cardiovascular reactivity and ambulatory blood pressure. Int J Neurosci (1997) 1.14
Racial differences in stress-induced cardiovascular reactivity and hypertension: current status and substantive issues. Psychol Bull (1989) 1.13
Effects of an angry temperament on coronary heart disease risk : The Atherosclerosis Risk in Communities Study. Am J Epidemiol (2001) 1.13
Elevated fasting plasma cortisol is associated with ischemic heart disease and its risk factors in people with type 2 diabetes: the Edinburgh type 2 diabetes study. J Clin Endocrinol Metab (2010) 1.11
Cardiovascular reactivity in cardiovascular disease: "once more unto the breach". Int J Behav Med (1994) 1.11
Lower lipid peroxide levels in practitioners of the Transcendental Meditation program. Psychosom Med (1998) 1.10
Catecholamine levels in practitioners of the transcendental meditation technique. Physiol Behav (2001) 1.07
The transcendental meditation technique, adrenocortical activity, and implications for stress. Experientia (1978) 1.06
Structural remodeling in hypertensive heart disease and the role of hormones. Hypertension (1994) 1.05
The relationship between trait hostility and cardiovascular reactivity: a quantitative review and analysis. Psychophysiology (1993) 1.05
A randomized controlled trial on effects of the Transcendental Meditation program on blood pressure, psychological distress, and coping in young adults. Am J Hypertens (2009) 1.05
Global health risks: progress and challenges. Bull World Health Organ (2009) 1.04
Mental stress as a causal factor in the development of hypertension and cardiovascular disease. Curr Hypertens Rep (2001) 1.04
A self-referential default brain state: patterns of coherence, power, and eLORETA sources during eyes-closed rest and Transcendental Meditation practice. Cogn Process (2009) 1.04
Autonomic patterns during respiratory suspensions: possible markers of Transcendental Consciousness. Psychophysiology (1997) 1.03
Preventing cardiovascular disease in the 21st century: therapeutic and preventive implications of current evidence. Am J Cardiovasc Drugs (2006) 1.03
Effects of Transcendental Meditation practice on brain functioning and stress reactivity in college students. Int J Psychophysiol (2008) 1.02
The relationship of anger expression to health problems among black Americans in a national survey. J Behav Med (1987) 1.01
An innovative approach to reducing medical care utilization and expenditures. Am J Manag Care (1997) 1.01
Medial profrontal cortex and anterior cingulate cortex in the generation of alpha activity induced by transcendental meditation: a magnetoencephalographic study. Acta Med Okayama (2006) 1.01
Effectiveness of transcendental meditation on functional capacity and quality of life of African Americans with congestive heart failure: a randomized control study. Ethn Dis (2007) 1.00
Relationship of trait anger to resting blood pressure: a meta-analysis. Health Psychol (1995) 0.98
The impact of the transcendental meditation program on government payments to physicians in Quebec. Am J Health Promot (1996) 0.97
Physiological patterns during practice of the Transcendental Meditation technique compared with patterns while reading Sanskrit and a modern language. Int J Neurosci (2001) 0.97
A randomized controlled trial of stress reduction in African Americans treated for hypertension for over one year. Am J Hypertens (2005) 1.45
Transcendental meditation does not predispose to epilepsy. Med Hypotheses (2005) 0.97
Clinical and Pre-clinical Applications of the Transcendental Meditation Program in the Prevention and Treatment of Essential Hypertension and Cardiovascular Disease in Youth and Adults. Curr Hypertens Rev (2006) 0.82
Reply to critics of research on transcendental meditation in the prevention and control of hypertension. J Hypertens (2005) 0.76
The use of meditation in corrections. Int J Offender Ther Comp Criminol (2010) 0.75